2017
DOI: 10.1016/j.ijantimicag.2017.01.041
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of intramuscular moxifloxacin in the treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
10
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 30 publications
0
10
0
Order By: Relevance
“…RIF, when used alone, is susceptible to drug resistance; therefore, RIF in combination with other antibiotics to gradually treat osteomyelitis has become a trend for treating chronic osteomyelitis [42]. MOX exhibits a wide antibacterial spectrum and high bioavailability within the bone [22]. In our study, both quantitative and qualitative antibacterial tests demonstrated that the combined drug-loaded microspheres exhibited more effective bacteriostasis than single drug-loaded microspheres.…”
Section: Discussionmentioning
confidence: 58%
See 1 more Smart Citation
“…RIF, when used alone, is susceptible to drug resistance; therefore, RIF in combination with other antibiotics to gradually treat osteomyelitis has become a trend for treating chronic osteomyelitis [42]. MOX exhibits a wide antibacterial spectrum and high bioavailability within the bone [22]. In our study, both quantitative and qualitative antibacterial tests demonstrated that the combined drug-loaded microspheres exhibited more effective bacteriostasis than single drug-loaded microspheres.…”
Section: Discussionmentioning
confidence: 58%
“…Moxifloxacin (MOX) is a fourth-generation quinolone and has excellent broad-spectrum antibacterial properties and low systemic toxicity; thus, it has been used for treating chronic osteomyelitis. In addition, previous studies have confirmed that compared with other antibiotics such as glycopeptides, clindamycin and RIF, MOX exhibits higher bioavailability and bone tissue penetration to enter bone cells and kill latent S. aureus [22].…”
mentioning
confidence: 84%
“…e experimental model MRSA osteomyelitis in rabbits was used by Soranglou et al [52] to evaluate the efficacy of intramuscular moxifloxacin, as well as by Taghipour et al [7] in a comparative study of the effect of vancomycin, enrofloxacin, and trimethoprim/sulfamethoxazole. Bacterial inoculation is more often performed directly by intra-articular injection [33,53].…”
Section: Discussionmentioning
confidence: 99%
“…Our choice can be explained by the fact that intravenous drug administration in rabbits is extremely challenging due to the lack of available veins, and it is not possible to maintain an intravenous catheter for a long time in a vigilant rabbit. Moreover, intramuscular administration of antibiotics can result in peak serum concentrations within minutes at levels comparable to those observed after intravenous injections [52]. During the experiment, we monitored not only the bacterial load in the bone marrow but also body temperature and body weight.…”
Section: Discussionmentioning
confidence: 99%
“… 4 , 5 Owing to the broad resistance of MRSA, these infections have become more difficult to control and represent a significant public health challenge. 6 MRSA is present not only in hospitals but has also appeared in other environments and food; therefore, there are many more opportunities for individuals to come into contact with MRSA. 7 10 …”
Section: Introductionmentioning
confidence: 99%